Functional blockage of EMMPRIN ameliorates atherosclerosis in apolipoprotein E-deficient mice

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 3248-3253

  Liu, Hong ^a   Yang, Li Xia ^b   Guo, Rui Wei ^b   Zhu, Guo Fu ^b   Shi, Yan Kun ^b   Wang, Xian Mei ^b   Qi, Feng ^b   Guo, Chuan Ming ^b   Ye, Jin Shan ^b   Yang, Zhi Hua ^b   Liang, Xing ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b KUNMING GENERAL HOSPITAL   (China)

Author keywords

Antibody; Atherosclerosis; EMMPRIN; Matrix metalloproteinases

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD147 ANTIGEN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RESPONSE; CELL MIGRATION; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; HEART PROTECTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ANTIBODY; ATHEROSCLEROSIS; EMMPRIN; MATRIX METALLOPROTEINASES;

ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, CD147; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DIET, HIGH-FAT; DOWN-REGULATION; MALE; METALLOPROTEASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEOLYSIS; RANDOM ALLOCATION;

EID: 84886247365     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.04.141     Document Type: Article

References (37)

1. P. Libby Inflammation in atherosclerosis Arterioscler Thromb Vasc Biol 32 2012 2045 2051
2. P. Dutta, G. Courties, and Y. Wei Myocardial infarction accelerates atherosclerosis Nature 487 2012 325 329
3. A.M. Kampoli, D. Tousoulis, and N. Papageorgiou Matrix metalloproteinases in acute coronary syndromes: current perspectives Curr Top Med Chem 12 2012 1192 1205
4. R. Virmani, A.P. Burke, A. Farb, and F.D. Kolodgie Pathology of the vulnerable plaque J Am Coll Cardiol 47 2006 C13 C18
5. E. Huet, E.E. Gabison, S. Mourah, and S. Menashi Role of emmprin/CD147 in tissue remodeling Connect Tissue Res 49 2008 175 179
6. K.T. Iacono, A.L. Brown, M.I. Greene, and S.J. Saouaf CD147 immunoglobulin superfamily receptor function and role in pathology Exp Mol Pathol 83 2007 283 295
7. S.M. Agrawal, and V.W. Yong The many faces of EMMPRIN - roles in neuroinflammation Biochim Biophys Acta 2011 1812 213 219
8. M. Back, D.F. Ketelhuth, and S. Agewall Matrix metalloproteinases in atherothrombosis Prog Cardiovasc Dis 52 2010 410 428
9. A.C. Newby Metalloproteinases and vulnerable atherosclerotic plaques Trends Cardiovasc Med 17 2007 253 258
10. T.C. Major, L. Liang, X. Lu, W. Rosebury, and T.M. Bocan Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma Arterioscler Thromb Vasc Biol 22 2002 1200 1207
11. P. Seizer, T. Schonberger, and M. Schott EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation Atherosclerosis 209 2009 51 57
12. R. Schmidt, A. Bultmann, and S. Fischel Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes Circ Res 102 2008 302 309
13. L.X. Yang, Z.H. Yang, R.W. Guo, J.S. Ye, and H. Liu Angiotensin II induces extracellular matrix metalloproteinase inducer expression via an AT1R dependent pathway in aortic atherosclerotic plaque in apolipoprotein E knockout mice J Renin Angiotensin Aldosterone Syst 13 2011 67 75
14. L.X. Yang, H. Liu, and R.W. Guo Angiotensin II induces EMMPRIN expression in THP-1 macrophages via the NF-kappaB pathway Regul Pept 163 2010 88 95
15. C. Schulz, M.L. von Bruhl, and V. Barocke EMMPRIN (CD147/Basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall J Thromb Haemost 9 2011 1007 1019
16. T.R. Lizarbe, C. Tarin, and M. Gomez Nitric oxide induces the progression of abdominal aortic aneurysms through the matrix metalloproteinase inducer EMMPRIN Am J Pathol 175 2009 1421 1430
17. C. Tarin, B. Lavin, M. Gomez, M. Saura, A. Diez-Juan, and C. Zaragoza The extracellular matrix metalloproteinase inducer EMMPRIN is a target of nitric oxide in myocardial ischemia/reperfusion Free Radic Biol Med 51 2011 387 395
18. E.A. Heller, E. Liu, and A.M. Tager Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells Circulation 113 2006 2301 2312
19. W. Ni, K. Egashira, and S. Kitamoto New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice Circulation 103 2001 2096 2101
20. S. Sukhanov, Y. Higashi, and S.Y. Shai IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice Arterioscler Thromb Vasc Biol 27 2007 2684 2690
21. K. Satoh, P. Nigro, and T. Matoba Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms Nat Med 15 2009 649 656
22. C.C. Liang, A.Y. Park, and J.L. Guan In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro Nat Protoc 2 2007 329 333
23. Z. Huang, L. Wang, S. Meng, Y. Wang, T. Chen, and C. Wang Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages Int J Cardiol 146 2011 153 158
24. S. Xie, R. Nie, and J. Wang Inhibiting extracellular matrix metalloproteinase inducer maybe beneficial for diminishing the atherosclerotic plaque instability J Postgrad Med 55 2009 284 286
25. C. Haug, C. Lenz, F. Diaz, and M.G. Bachem Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase inducer (EMMPRIN) release by coronary smooth muscle cells Arterioscler Thromb Vasc Biol 24 2004 1823 1829
26. N. Abe, T. Osanai, T. Fujiwara, K. Kameda, T. Matsunaga, and K. Okumura C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: inhibitory effect of fluvastatin Life Sci 78 2006 1021 1028
27. H. Ge, J.F. Zhang, and B.S. Guo Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma Vascul Pharmacol 46 2007 114 121
28. P. Seizer, T. Schonberger, and M. Schott EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation Atherosclerosis 209 2010 51 57
29. Y.W. Yoon, H.M. Kwon, and K.C. Hwang Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque Atherosclerosis 180 2005 37 44
30. S.M. Agrawal, C. Silva, W.W. Tourtellotte, and V.W. Yong EMMPRIN: a novel regulator of leukocyte transmigration into the CNS in multiple sclerosis and experimental autoimmune encephalomyelitis J Neurosci 31 2011 669 677
31. N.R. Dean, J.R. Newman, and E.E. Helman Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer Clin Cancer Res 15 2009 4058 4065
32. W.M. Gwinn, J.M. Damsker, and R. Falahati Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention J Immunol 177 2006 4870 4879
33. J.M. Damsker, I. Okwumabua, T. Pushkarsky, K. Arora, M.I. Bukrinsky, and S.L. Constant Targeting the chemotactic function of CD147 reduces collagen-induced arthritis Immunology 126 2009 55 62
34. A. Trachtenberg, T. Pushkarsky, S. Heine, S. Constant, B. Brichacek, and M. Bukrinsky The level of CD147 expression correlates with cyclophilin-induced signalling and chemotaxis BMC Res Notes 4 2011 396
35. J.M. Yang, P. O'Neill, and W. Jin Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim J Biol Chem 281 2006 9719 9727
36. Q. Hou, X. Tang, and H. Liu Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147 Cancer Sci 102 2011 1287 1292
37. X. Liao, J.C. Sluimer, and Y. Wang Macrophage autophagy plays a protective role in advanced atherosclerosis Cell Metab 15 2012 545 553